Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 2451 |
VI
Versor Investments
New York
| $0 | -$971K | 0 | – | Closed |
|
| 2452 |
VFA
Virtus Fund Advisers
Hartford,
Connecticut
| $0 | -$27.9K | 0 | – | Closed |
|
| 2453 |
VIA
Virtus Investment Advisers
Hartford,
Connecticut
| $0 | -$296K | 0 | – | Closed |
|
| 2454 |
WI
Wahed Invest
New York
| $0 | -$104K | 0 | – | Closed |
|
| 2455 |
WAM
Warberg Asset Management
Winnetka,
Illinois
| $0 | -$14.1K | 0 | – | Closed |
|
| 2456 |
WTB
Washington Trust Bank
Spokane,
Washington
| $0 | -$2K | 0 | – | Closed |
|
| 2457 |
WOSD
WFA of San Diego
San Diego,
California
| $0 | -$8.88K | 0 | – | Closed |
|
| 2458 |
WAS
Winch Advisory Services
Appleton,
Wisconsin
| $0 | $0 | 1 | 0% | Maintained |
|
| 2459 |
ZCM
Ziegler Capital Management
Chicago,
Illinois
| $0 | -$346K | 0 | – | Closed |
|
| 2460 |
ZIG
Zullo Investment Group
Scranton,
Pennsylvania
| $0 | -$84.5K | 0 | – | Closed |
|